Stock comparison
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$105.09BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
CAMX.ST 24 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CAMX.ST2wins
4winsSANOFICONR.BO
78B
B78
91A
A89
94A
B83
65C
B77
63C
A91
77B
A86
77B
A85
Side-by-side metrics
| Metric | CAMX.ST | SANOFICONR.BO |
|---|---|---|
| Market cap | $36.93B | $105.09B Winner |
| P/E (TTM) | Winner: 42.6x | 44.0x |
| EV/EBIT | Winner: 29.5x | 31.7x |
| ROIC (TTM) | 17.17% | 59.15% Winner |
| Gross margin | Winner: 93.11% | 68.13% |
| Net margin | Winner: 32.47% | 27.35% |
| Revenue CAGR 5y | Winner: 33.3% | 27.01% |
| EPS CAGR 5y | Winner: 132.79% | 20.67% |
| Debt / Equity | Winner: 0.0x | 0.1x |
| Dividend yield | - | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CAMX.ST leads on
- EPS CAGR 5y132.79%vs 20.67%+84%
- Debt / Equity0.0xvs 0.1x+61%
- Gross margin93.11%vs 68.13%+27%
- Revenue CAGR 5y33.3%vs 27.01%+19%
SANOFICONR.BO leads on
- ROIC (TTM)59.15%vs 17.17%+71%
- Market cap$105.09Bvs $36.93B+65%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.